| Amgen Switzerland AG - XGEVA 120 mg/1 ml, Injektionslösung in einer Fertigspritze |
| 69520 | | 01 | | XGEVA 120 mg/1 ml | | Injektionslösung in einer Fertigspritze | | M05BX04 | | Denosumab | | 18.09.2024 | | |
|
| Composition |
| denosumabum 120 mg, sorbitolum 37 mg, phenylalaninum 6.1 mg, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium max. 0.6 mg. |
| Packungsbestandteile |
| Injektionslösung in Fertigspritze | | | | | | | | | BAG: Active Agent | Dose |
|---|
| | 120 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Natrii Hydroxidum | | | Phenylalaninum | 6.1 mg | | | | | Sorbitolum | 37 mg |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 379.81 | 429.50 | A | SL | No |
|
